Evidence, Pricing and Access Congress – 13-15th April 2021 – Virtual Congress – Central European Time


We are very pleased to announce that our President Mary Lynne van Poelgeest will be chairing a plenary session on Tuesday 13th April 2021 at 14.55-16.40 CET.

There will be a live interview with Ryan Saadi (CEO, TEVOGEN BIO) on Achieving greater cooperation between stakeholders to improve outcomes for the patient, Tuesday 13th April 2021 at 15-15.20 CET.

Furthermore, there will be a Keynote Panel Discussion: Understanding what value truly means for pharma, payers, HTAs and patients and how we can bridge the gaps, Tuesday 13th April 2021 at 15.40-16.40 CETwith the following panellists :

  • Martin Schuchardt, Global Market Access Lead, Almirall
  • Adam Kundzewicz, Global Head of Strategic Market Access Initiatives, Boehringer Ingelheim
  • Mike Crosher, Managing Director, Chugai Pharma UK Ltd
  • Nuriya Musina, Chief of development and communications, Center of Healthcare Quality Assessment and Control, The Ministry of Health of the Russian Federation
  • Trevor Richter, Director, Pharmaceutical Reviews, Canadian Agency for Drugs and Technologies in Health
  • Saira Jan, Vice-President & Chief Pharmacy Officer, Horizon Blue Cross Blue Shield of New Jersey and Professor, Emerita, Rutgers University